FDA meeting to evaluate Mevacor going OTC

The approval is based on the FINEARTS-HF (NCT04435626), showing that the drug achieved a 16% relative risk reduction of cardiovascular death and total heart failure events.

Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.

The therapy is now the first and only oral on demand treatment option for the condition.

Learn more about the ins and outs of pharmacy ownership from the experts at First Financial Bank.

Bullous pemphigoid is a rare skin condition that causes large blisters filled with fluids that typically occur near skin creases, such as the upper thighs and armpits.

Alkaptonuria affects approximately 1 in 250,000 to 1 million people in the United States.